Andreas Prachalias
Overview
Explore the profile of Andreas Prachalias including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Florou E, Anand U, Govindu E, Gregory S, Prachalias A
Cureus
. 2024 Dec;
16(11):e74099.
PMID: 39712734
Injuries to the inferior vena cava (IVC) carry high risks and mortality rates. We present a case of suprahepatic IVC injury that was successfully treated with polytetrafluoroethylene (PTFE) graft insertion...
2.
Tavabie O, Patel V, Salehi S, Stamouli M, Trovato F, Maxan M, et al.
Sci Rep
. 2024 Oct;
14(1):23831.
PMID: 39394217
As the global prevalence of chronic liver disease continues to rise, the need to determine which patients will develop end-stage liver disease and require liver transplantation is increasingly important. However,...
3.
Vijayashanker A, Aluvihare V, Suddle A, Sanchez-Fueyo A, Cerisuelo M, Melendez H, et al.
J Liver Transpl
. 2023 Nov;
9:100131.
PMID: 38013774
Background: As the world recovers from the aftermath of devastating waves of an outbreak, the ongoing Coronavirus disease 2019 pandemic has presented a unique perspective to the transplantation community of...
4.
Jagatia R, Doornebal E, Rastovic U, Harris N, Feyide M, Lyons A, et al.
EBioMedicine
. 2023 Oct;
97:104826.
PMID: 37806285
Background: The exploitation of anti-tumour immunity, harnessed through immunomodulatory therapies, has fundamentally changed the treatment of primary liver cancer (PLC). However, this has posed significant challenges in preclinical research. Novel...
5.
McClements J, Valle J, Blackburn L, Brooks A, Prachalias A, Dasari B, et al.
Br J Surg
. 2023 Aug;
110(12):1673-1676.
PMID: 37611144
No abstract available.
6.
Sousa Da Silva R, Breuer E, Shankar S, Kawakatsu S, Holowko W, Coelho J, et al.
Ann Surg
. 2023 Jul;
278(5):748-755.
PMID: 37465950
Objective: This study aims at establishing benchmark values for best achievable outcomes following open major anatomic hepatectomy for liver tumors of all dignities. Background: Outcomes after open major hepatectomies vary...
7.
Tavabie O, Kronsten V, Przemioslo R, McDougall N, Ramos K, Joshi D, et al.
Frontline Gastroenterol
. 2023 Jul;
14(4):334-342.
PMID: 37409334
Introduction: Liver transplantation (LT) remains integral to the management of end-stage chronic liver disease (CLD). However, referral thresholds and assessment pathways remain poorly defined. Distance from LT centre has been...
8.
Ivanics T, Claasen M, Patel M, Giorgakis E, Khorsandi S, Srinivasan P, et al.
Liver Int
. 2023 Feb;
43(5):1107-1119.
PMID: 36737866
Background And Aims: Identifying international differences in utilization and outcomes of liver transplantation (LT) after donation after circulatory death (DCD) donation provides a unique opportunity for benchmarking and population-level insight....
9.
Ghaneh P, Palmer D, Cicconi S, Jackson R, Halloran C, Rawcliffe C, et al.
Lancet Gastroenterol Hepatol
. 2022 Dec;
8(2):157-168.
PMID: 36521500
Background: Patients with borderline resectable pancreatic ductal adenocarcinoma have relatively low resection rates and poor survival despite the use of adjuvant chemotherapy. The aim of our study was to establish...
10.
Halloran C, Neoptolemos J, Jackson R, Platt K, Psarelli E, Reddy S, et al.
Ann Surg Open
. 2022 Oct;
3(3):e198.
PMID: 36199490
Importance: Complications driven by POPF following pancreatic cancer resection may hinder adjuvant therapy, shortening survival. BA may reduce complications compared to CWA, improving the use of adjuvant therapy and prolonging...